參考文獻(xiàn)/References:
[1] 管紅珍,彭智聰,傅鷹.循證醫(yī)學(xué)中文獻(xiàn)證據(jù)等級(jí)標(biāo)準(zhǔn)的系統(tǒng)性綜述[J].藥物流行病學(xué)雜志,2002,11(3):145-148.
[2] 高學(xué)敏.中藥學(xué)[M].2版.北京:中國(guó)中醫(yī)藥出版社,2007.
[3] 宋紅梅,吳斌,魏迎辰,等.溫陽(yáng)補(bǔ)腎方對(duì)激素性股骨頭壞死模型兔股骨頭形態(tài)學(xué)的影響[J].中國(guó)中醫(yī)骨傷科雜志,2014,22(3):1-3.
[4] 宋紅梅,吳斌,魏迎辰,等.溫陽(yáng)補(bǔ)腎方對(duì)兔激素性股骨頭壞死血清OPG、RANK、RANKL的影響[J].中國(guó)中醫(yī)骨傷科雜志,2013,21(12):1-7.
[5] 李曦,張麗宏,王曉曉,等.當(dāng)歸化學(xué)成分及藥理作用研究進(jìn)展[J].中藥材,2013,36(6):1023-1028.
[6] Kim YC,Quan FS,Song JM,et al.Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles[J].Procedia in Vaccinology,2010,2(1):17-21.
[7] 張波,徐博,吳昊,等.續(xù)斷對(duì)兔骨折愈合過(guò)程中相關(guān)基因表達(dá)和血鈣、磷含量的影響[J].氨基酸和生物資源,2016,38(2):54-57.
[8] 張佩,董路玨,李義凱.新傷續(xù)斷湯對(duì)成骨細(xì)胞增殖及骨形態(tài)發(fā)生蛋白的影響[J].廣州中醫(yī)藥大學(xué)學(xué)報(bào),2016,(1):92-97.
[9] Zhou Z,Lin J,Huo R,et al.Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4/5 signaling in vivo[J].Int Immunopharmacol,2012,14(3):275-282.
[10] 孟祥龍,馬俊楠,張朔生,等.熟地黃炮制(九蒸九曬)過(guò)程中藥效化學(xué)成分量變化及炮制輔料對(duì)其影響研究[J].中草藥,2016,47(5):752-759.
[11] 賈英民,李瑞玉,武密山,等.地黃梓醇對(duì)原代培養(yǎng)SD乳大鼠成骨細(xì)胞成骨活性的影響研究[J].現(xiàn)代中西醫(yī)結(jié)合雜志,2015,24(23):2524-2526.
[12] 李三華,劉坤祥,莫寧萍,等.RT-PCR法檢測(cè)杜仲總黃酮對(duì)大鼠成骨細(xì)胞骨鈣素表達(dá)的影響[J].遵義醫(yī)學(xué)院學(xué)報(bào),2011,34(3):223-225.
[13] 王日生.活血化瘀中藥藥理作用探析[J].亞太傳統(tǒng)醫(yī)藥,2014,10(4):74-75.
[14] 張周.川芎嗪對(duì)心血管保護(hù)的藥理學(xué)作用和臨床應(yīng)用進(jìn)展[J].中國(guó)實(shí)用醫(yī)藥,2009,4(7):129-130.
[15] 吳江瑩,吳江雁,劉曉新.五種中藥抗血小板作用機(jī)制及在防治缺血性卒中中的應(yīng)用[J].中西醫(yī)結(jié)合心腦血管病雜志,2015,13(13):1500-1503.
[16] 于大永,呂曉超,史麗穎,等.牛膝中三萜皂苷抑制破骨細(xì)胞分化作用的研究[J].中國(guó)中醫(yī)骨傷科雜志,2011,19(3):9-10.
[17] 周江濤,王慶來(lái),趙依娜,等.牛膝含藥血清對(duì)骨關(guān)節(jié)炎軟骨細(xì)胞P38絲裂原活化蛋白激酶信號(hào)轉(zhuǎn)導(dǎo)通路的影響[J].中醫(yī)正骨,2012,24(12):15-19.
[18] 李曉明,郭東輝,石國(guó)君,等.髓芯減壓聯(lián)合丹參酮ⅡA混合植骨治療FicatⅡ期股骨頭壞死[J].中醫(yī)正骨,2014,26(5):9-12.
[19] 上官文姬,李鶴,湯璐敏.骨碎補(bǔ)總黃酮對(duì)大鼠成骨細(xì)胞VEGF和FGF-2表達(dá)的影響[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2014,16(8):38-41.
[20] 張琳,沈國(guó)舜,張鏡年,等.羥基紅花黃色素A的血管作用及其機(jī)制研究[J].上海交通大學(xué)學(xué)報(bào):醫(yī)學(xué)版,2009,29(4):431-434.
[21] 萬(wàn)甜,吳敏瑞,齊振熙.羥基紅花黃色素A對(duì)激素誘導(dǎo)骨髓間充質(zhì)干細(xì)胞成骨分化的影響[J].中國(guó)骨傷,2014,(3):224-228.
[22] 齊振熙,萬(wàn)甜,洪昆達(dá),等.羥基紅花黃色素A對(duì)激素性股骨頭缺血壞死兔股骨頭組織JNK1表達(dá)的影響[J].中華中醫(yī)藥雜志,2014,29(12):3962-3965.
[23] 蔣海峰,宿樹(shù)蘭,歐陽(yáng)臻,等.乳香、沒(méi)藥提取物及其配伍對(duì)血小板聚集與抗凝血酶活性的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2011,17(19):160-165.
[24] 黃鎮(zhèn)林,何亮穎,王宏濤,等.土鱉蟲(chóng)活性組分F2-2體內(nèi)抗凝藥效實(shí)驗(yàn)[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2014,16(6):1359-1363.
相似文獻(xiàn)/References:
[1]白春曉,賈育松,孫旗,等.中醫(yī)藥在腰椎間盤(pán)突出癥圍手術(shù)期應(yīng)用的研究進(jìn)展[J].中醫(yī)正骨,2015,27(11):65.
[2]江建春.神經(jīng)根型頸椎病的中醫(yī)藥治療研究概況[J].中醫(yī)正骨,2015,27(11):71.
[3]田正強(qiáng).消腫止痛散外敷聯(lián)合繃帶固定治療急性踝關(guān)節(jié)扭傷[J].中醫(yī)正骨,2015,27(10):28.
[4]劉枝城,董霞,謝正虎,等.手法整復(fù)小夾板鋼絲托板固定治療兒童新鮮孟氏骨折[J].中醫(yī)正骨,2015,27(10):55.
[5]沈海良,錢(qián)萬(wàn)鋒,周驍棟.針刀松解聯(lián)合局部封閉與口服中藥治療腰椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(09):46.
[6]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型
血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):1.
[7]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[8]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[9]任博文,楊豪.口服桂葛萆薢湯加減配合功能鍛煉治療
寒濕型腰椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(08):53.
[10]趙新杰,孫實(shí),武愛(ài)玲.中醫(yī)藥治療膝關(guān)節(jié)滑膜炎的研究進(jìn)展[J].中醫(yī)正骨,2015,27(08):65.
[11]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[12]姚晨,沈計(jì)榮,杜斌,等.口服補(bǔ)腎活血湯聯(lián)合微創(chuàng)保髖術(shù)治療股骨頭壞死腎虛血瘀證的臨床研究[J].中醫(yī)正骨,2016,28(11):7.
YAO Chen,SHEN Jirong,DU Bin,et al.Clinical study on oral application of Bushen Huoxue Tang(補(bǔ)腎活血湯)combined with minimally invasive hip-preserving surgery for treatment of kidney-deficiency-blood-stasis-type osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):7.
[13]宋夢(mèng)歌,李記天,薛志鵬,等.股骨頭壞死保髖治療的臨床療效分析[J].中醫(yī)正骨,2020,32(01):36.
[14]魏秋實(shí),李子祺,袁穎嘉,等.“標(biāo)本兼治”理論在股骨頭壞死中醫(yī)藥治療中的指導(dǎo)作用[J].中醫(yī)正骨,2020,32(01):56.
[15]顧勇,趙艷明,童培建,等.基于數(shù)據(jù)挖掘法探討中藥復(fù)方治療股骨頭壞死的組方規(guī)律[J].中醫(yī)正骨,2021,33(06):49.
GU Yong,ZHAO Yanming,TONG Peijian,et al.A study of medication rule of Traditional Chinese Medicine compounds for treatment of osteonecrosis of femoral head based on data mining approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(08):49.
[16]張應(yīng)拴,邢濤,李盛華,等.名中醫(yī)治療股骨頭壞死的用藥規(guī)律分析[J].中醫(yī)正骨,2021,33(09):73.
ZHANG Yingshuan,XING Tao,LI Shenghua,et al.Experience of prominent TCM doctors An analysis of clinical medication rules of prestigious TCM doctors in treatment of femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(08):73.